Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Centrum für Angewandte Nanotechnologie (CAN) was founded in 2005 in Hamburg, Germany, as a public-private partnership to advance nanotechnology research and provide contract R&D services. In January 2018, CAN GmbH was integrated into the Fraunhofer Institute for Applied Polymer Research (IAP) and now operates as the Fraunhofer Center for Applied Nanotechnology CAN. The center specializes in the synthesis, characterization, and application of inorganic nanoparticle systems and nanocomposites. Its technology is utilized across various sectors, including life sciences (for diagnostics, biomarkers, and targeted drug delivery), home and personal care, and functional materials. CAN's proprietary semiconductor nanoparticles are commercially distributed worldwide under the brand name CANdot.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centrum für Angewandte Nanotechnologie.